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A B S T R A C T   
Purpose: Focal Cortical Dysplasias (FCD) are localized malformative brain lesions in epilepsy. FCD3a associated 
with hippocampal sclerosis, affects the superficial cortex and is presumed to have an ‘acquired’ rather than 
developmental origin. Precursor cells may arise outside neurogenic zones including cortical layer I. Our aim was 
to characterise subsets of glial progenitor cells in the superficial cortical layers, known to be involved in gliosis 
and gliogenesis and that could distinguish FCD3a from other subtypes. 
Methods: Using immunohistochemistry we quantified the density of glial progenitor subsets in superficial cortex 
layers using markers against PAX6, GFAP, Olig2 and PDGFRβ and proliferation marker MCM2 in ten FCD3a cases 
compared to 18 other FCD types and 11 non-FCD controls. 
Key findings: Glial progenitor cells types were present in the cortical layer I and II in all FCD groups. GFAP cells 
frequently expressed PAX6 and significantly higher GFAP/PAX6 than GFAP/MCM2 cell densities were identified 
in the FCD3a group (p < 0.05). Olig2 cell densities were significantly higher in FCD3b than FCD3a (p = 0.002) 
and significantly higher GFAP/MCM2 compared to PDGFRβ/MCM2 cell densities were identified in both FCD3b 
and FCD2 groups. There was no correlation between cell densities and the age of patients at surgery and between 
cortical regions. 
Significance: Immature and proliferative glial populations across FCD variants reflect reactive cell types and 
differences may provide insight into underlying pathomechanisms. Higher PAX6 expression in astroglial cells in 
FCD3a may indicate a switch to astrocytic maturation and enhanced superficial gliosis. Higher Olig2 and GFAP/ 
MCM2 densities in FCD3b may reflect margins of the tumour infiltration zone rather than true cortical dysplasia.   
1. Introduction 
Focal cortical dysplasia (FCD) type 3a is a cytoarchitectural change 
encountered in approximately 10 % of patients with Temporal Lobe 
Epilepsy and Hippocampal Sclerosis (TLE/HS). FCD3a principally in-
volves the superficial cortical layers with abnormal clustering of neu-
rones in layer II, reduction of neurones in the lower part of layer II/III 
and accompanying laminar gliosis (Blumcke et al., 2011). This FCD 
pattern has been argued to represent an acquired post-natal reorgan-
izational dysplasia, impairing normal maturation, likely to be both 
aetiologically and temporally linked with the development of HS, 
although its functional significance remains unclear (Thom et al., 2009). 
The superficial cortical layers are highly relevant to seizure propagation 
through extensive cortical-cortical networks and generation of slow 
rhythms (Halgren et al., 2018) ; discharges from the superficial cortex 
spread over a larger area than deeper cortex (Serafini et al., 2015), 
recruitment of layer II/III neurones plays a critical role in seizure spread 
(Brodovskaya and Kapur, 2019) and activation of cAMP-response 
element binding protein, a neuronal activity biomarker, was recently 
shown only in layer II neurones of epilepsy surgical resections (De Santis 
et al., 2020). There is also a body of evidence of the integral role of 
astroglia and glial-neuronal interactions in the pathophysiology of 
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epilepsy (Patel et al., 2019) which are less explored in the superficial 
cortex. 
The superficial cortical layers are the last to form during develop-
ment with complete maturation extending into post-natal period. 
Experimental studies show deficient Robo1-mediated signalling, that 
regulates normal neuronal migration to the superficial layers, results in 
abnormal distribution of neurones in layer II and III during the post- 
natal stages (Gonda et al., 2013), reminiscent of patterns in FCD3a. 
Population of reelin-secreting Cajal Retzius neurones persist in layer I 
into adulthood regulating dendritic complexity (Meyer and 
Gonzalez-Gomez, 2018) and persistent immature doublecortin-positive 
neurones are recognised at the interface of layer I and II (Bonfanti and 
Nacher, 2012) including in TLE/HS, although their physiological func-
tion is unclear (Liu et al., 2018a). In addition to immature neurones, 
glial progenitor cell types are recognised in the superficial cortex and 
indeed the marginal zone is regarded as a less explored progenitor 
‘niche’ during development (Costa et al., 2007). Previously, we have 
reported populations of developmentally regulated GFAP∂-positive glia 
in FCD (Martinian et al., 2009) and proliferative nestin-expressing glial 
cells localised in cortical layer I in TLE/HS (Liu et al., 2018b). 
We hypothesised that glial progenitor cell types are integral to both 
the development and phenotype of FCD3a. Our aim was to evaluate this 
using paired-box transcription factor (PAX6), which has developmental 
regulatory roles in differentiation and proliferation of astrocytes 
(Sakurai and Osumi, 2008), Olig2 transcription factor, regulating 
oligodendroglial progenitor cells (Mitew et al., 2014) and platelet 
derived growth factor receptor (PDGFRβ) as a marker for NG-2 pro-
genitor subsets (Garbelli et al., 2015) in FCD3a compared to other 
dysplasia types and non-FCD controls. 
2. Methods 
39 surgical cases were selected from the archives of the Epilepsy 
Society Brain and Tissue Bank which included ten representative cases 
of FCD3a, eighteen cases with other FCD subtypes (FCD1, 2, 3b, 3b, 3d), 
seven cases with ILAE type I HS and no dysplasia and four non-epilepsy 
controls ; FCD subtypes were determined using current ILAE criteria 
(Blumcke et al., 2011) (Table 1). The majority of the resections were 
Table 1 
Table of the 39 cases and quantitative data of layer I/II single labelled cells.  












































Mean (SD) Mean (SD) Mean (SD)           
[Densities 
DL cells 








mean, SD / 
mm2] 
FCD3A 32 .2 9.3 70 % HS (10) T 100 % 50 % 71.41 11.89 50.4 # 11.6 % 55% 33 % 
N¼10 (19− 47) (2− 17)     (18.76) (9.8) (23) (9) (35) (11)           
[10,11] [97.1, 99.0] [7.6,8.5] 




146.1 11.75 141.3 
# 
35 % 73 % 32 % 
N¼6 (22− 36) (1− 17)   O 16.7 
%  
(18.76) (3.5) (100) (26) (19) (15)           
[56,52] [62.7,41.6] [6.8,6.5] 





T 100 % 50 % 79.8 4.08 51.98 
(24.3) 
19 % 53 % 41 % 
N¼4 (17− 33) (3− 14)     (23.35) (5.3)  (11) (37) (52)           
[18.7,27.1] [69.6,61.6] [2.2,3.4] 
FCD2A/ 
B 
32 6 0% – T 60 % 20 % 116.86 12.40 65.2 18 % 31 % 16 % 
N¼5 (18− 52) (3− 8)   F 40 %  (63.3) (8.3) (52.7) (14) (23) (19)           
[24.3,23.9] [37.9,40.6] [2.6, 2.56] 
FCD1A 5.6 (3− 11) N/A – T 77 % N/A 86.11 24.76~ 54.37 4% 82 % 19 % 
N¼3  N/A   O 33 %  (47.9) (7.0) (8.8) (2) (22) (16)           
[2.87, 2.8] [62.5,22.3] [7.5,7.8] 
HS-NO 
FCD 
42.7 10.2 20 % – T 100 % 60 % 138.5 5.83 52.43 9.8 % 61 % 42 %           
(9.6) (20) (5) 
N¼7 (35− 52) (4− 21)     (83.2) (4.2) (34) {5.8,6.2] [48.5,24.0] [4.5,4.1] 
NEC 39.7 N/A N/A Normal cortex 
for raised ICP 
(1), adjacent to 
tumour (3) 
T 100 % 100 
% 
112.9 1.16 N/A 24 % 57 % 33 % 
N¼4 (18− 74)      (51.0) (1.3)  (19) (37) (57)           
[21.9,28.2] [54.6, 31.8] [0.3,0.6] 




#    
Significance (Sig.) between groups shown in bold (~Kruskal Wallis test for all groups, # Mann-Whitney test between 2 groups). DL=double labelled, DNT = Dys-
embryoplastic neuroepithelial tumour, F = Frontal cortex, FS = febrile seizures, FCD = Focal cortical dysplasia, GG = Ganglioglioma, ICP = raised intracranial 
pressure, HS = hippocampal sclerosis, N = non epilepsy controls, N/A = data not available or not applicable, T = temporal lobe, O = occipital cortex, SD = Standard 
deviation. *not all cases were analysed for all immunostains and olig2 IHC was not carried out in NEC group. 
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temporal cortex and there was consent for use of tissue and ethical 
approval for this study. 
Immunohistochemistry was carried out on 5 μm formalin-fixed 
paraffin-embedded brain sections using anti-NeuN (1:100, Millipore, 
UK), anti-MCM2 (Mini-chromosome maintenance protein 2 for cells 
licensed for replication, 1:900, BD biosciences, UK), anti-PAX6 (1:100, 
Santa Cruz Biotech. UK), anti-GFAP (1:1500, DAKO, UK) and anti-
–PDGFRβ (1:1000, Abcam, UK) as described in previous studies (Liu 
et al., 2018a; Liu et al., 2018b). Chromogenic double immunolabelling 
for GFAP/MCM2, GFAP/PAX6 and PDGFRβ/MCM2 was performed 
using NovaRED Substrate Kit (Vector Lab; Peterborough, UK) and DAKO 
REAL Envision HRP/DAB kit (Agilent Technologies; Cheshire, UK). The 
region of interest for analysis was defined on NeuN-labelled sections 
using an Zeiss Axioscope microscope at x2.5 and the image analysis 
programme, Histometrix 6 (Kinetic Imaging Limited; Liverpool, UK) to 
include all of layer I and the upper part of layer II (approximate depth of 
3 mm from the pia) of a single gyrus where dysplasia was present. For 
cases without dysplasia, a similar region of interest along the middle 
temporal gyrus was examined in each case (Fig. 1A). Manual cell counts 
of single and double-labelled cells per area (cell numbers/μm2) were 
performed at 40x magnification for the entire ROI. Quantification was 
repeated in half of the cases, and the interclass correlation coefficients 
ranged between 0.92 and 0.95. Perivascular PDGFRβ cells, which may 
be pericytes, were not included in the counts. Results were compared 
between FCD subtypes and controls using corrected non-parametric 
statistical methods (SPSS v25, IBM, New York, USA). 
3. Results 
Qualitative assessment of immunolabelling with NeuN labelling 
confirmed the subtype of FCD including the typical clustering of neu-
rones in layer II that defines FCD3a as distinct from other FCDs and 
normal cortex (Fig. 1B-C). PAX6, MCM2, GFAP, Olig2 and PDGFRβ- 
labelled cells were observed in the superficial cortex in FCD3a (Fig. 1) 
and also other FCD types (supplemental Fig. 1). PAX6 immunolabelling 
was exclusively observed within nuclei, as confirmed by immunofluo-
rescent studies and confocal microscopy where PAX6 positive labelling 
was stained with DAPI, a nuclear marker (Fig. 1D, inset). PAX6/GFAP 
co-labelled cells, including binucleated cells, were often observed in 
layer I (Fig. 1D) and GFAP processes were prominent in the immediate 
subpial layer. MCM2-labelled nuclei were also found to scatter 
throughout the superficial cortex, sometimes co-labelled with GFAP 
(Fig. 1E). Olig2 marker also showed nuclear labelling of small cells in 
layer I and II (Fig. 1F). Single PDGFRβ-labelled small cells were scattered 
in the superficial layers, many with multiple short processes extending 
in the parenchyma, some in proximity to neurones and PDGFRβ multi-
nucleated cells were also noted (Fig. 1G,H and insets). PDGFRβ, in 
addition, labelled pericyte-like cells in close proximity to small vessels, 
but no labelling of cell processes in the subpial region was observed as 
with GFAP. A proportion of PDGFRβ-labelled cells were MCM2 positive 
(Fig. 1). 
Quantitative evaluation showed variability in labelling between 
cases (Table 1). For single labelled cells, significantly higher PDGFRβ 
cell densities were present in FCD1a than other FCD groups (Table 1; p =
0.01 Kruskal Wallis test) and significantly higher Olig2 cell densities in 
FCD3b than FCD3a (Table 1; p = 0.002 Mann-Whitney test) (Fig. 1J). 
For double labelled cells, no significant differences were noted between 
groups for either cell densities or proportions of double labelled cells 
(Table 1) although lowest densities were observed in HS cases without 
dysplasia (Fig. 1J). Wilcoxon rank test for within group differences 
showed significantly higher GFAP/PAX6 than GFAP/MCM2 densities in 
FCD3a (p < 0.05); significantly higher GFAP/MCM2 than PDGFRβ/ 
MCM2 densities were present in both FCD3b and FCD2 groups (Fig. 1J). 
There was no correlation between any cell densities and the age of pa-
tients at surgery, age of onset of epilepsy, history of febrile convulsions 
and no significant differences noted between temporal and extra- 
temporal regions. 
4. Discussion 
We observed a range of glial progenitor cell types in cortical layer I 
and II common to FCD types but with differences that could reflect their 
underlying aetiology. Our aim was to compare FCD3a which primarily 
involves the superficial cortex to other ‘pan-cortical’ FCD and one 
finding was higher PAX6/GFAP than GFAP/MCM2 co-labelled cells in 
FCD3a. PAX6 is a transcription factor and stem cell marker, primarily 
expressed in radial glia during development with roles in cortical 
patterning (Ypsilanti and Rubenstein, 2016). In the adult murine cortex, 
PAX6 is expressed primarily in astrocytes and shown to have a negative 
effect on cell proliferation, promoting maturation (Sakurai and Osumi, 
2008). PAX6 or MCM2 expressing GFAP cells may represent either 
‘reactivated mature astrocytes’ or progenitor cell types and increased 
PAX6-expressing astroglial cell densities in the vicinity of acute cortical 
injuries were detected in our previous studies (Goc et al. 2014) sug-
gesting they represent regenerative and dynamic cell populations. The 
frequent bi-nucleation of PAX6-expressing cells in layer I of FCD3a cases 
may also reflect recent cell division, similar to observations with GFAP∂ 
labelling (Martinian et al., 2009). The predominance of GFAP/PAX6 
over GFAP/MCM2 in FCD3a may reflects a shift towards glial matura-
tion, reflected in the marked superficial cortical gliosis associated with 
neuronal re-organisation in this pathology (Thom et al., 2009). 
PDGFRβ is known to be expressed in brain parenchymal cells other 
than pericytes, including NG-2 cells, and show dynamic changes in 
number, proliferation and distribution following seizures and cortical 
injury (Garbelli et al., 2015; Kyyriainen et al., 2017; Reeves et al., 2019). 
In the current study, higher PDGFRβ cell densities in FCD1a were noted, 
but as the numbers within this subgroup was small, the significance of 
this requires further investigation, particularly since the proportion of 
proliferative (MCM2 positive) PDGFRβ cells was overall low in this 
group (Table 1). The proliferative fractions of PDGFRβ cells were higher 
in FCD3a than FCD2 but at similar levels to TLE/HS without dysplasia. 
Significantly lower densities of PDGFRβ/MCM2 compared to 
GFAP/MCM2 cells were noted in both FCD2 and FCD 3b; although 
PDGFRβ parenchymal cells have been reported in FCD2 the lower 
Fig. 1. Glial progenitor cell types in the superficial cortical layers of FCD cases. 
A. Superficial cortex showing the region of interest drawn to include cortical layer I and II of each case; this is an epilepsy control case with no dysplasia, so the 
middle temporal gyrus, inked in black along the meninges, was examined. B. NeuN labelling in a case with no dysplasia in the superficial cortex compared to (C) a 
case with the typical features of FCD3a (or temporal lobe sclerosis) with clustering of neurones in layer II and gaps in the lower part of the layer. D. In FCD3a, PAX6 
showed nuclear labelling (inset shows co-labelling of PAX6 with nuclear counterstain, DAPI) in a high proportion of GFAP-labelled cells in the superficial cortex 
(arrow), including multinucleated cells (wavy arrow). Occasionally, PAX6-labelled cells were GFAP-negative (arrowhead). E. In FCD3a, co-labelled MCM2/GFAP 
(arrow; inset) and single labelled MCM2 cells (arrowhead) were observed. F. Olig2 immunohistochemistry identified small, round cells scattered throughout the 
superficial layers (arrowheads). G Single (arrowheads) and multinucleated PDGFRβ-labelled cells (wavy arrow in inset) were found in the superficial cortex. PDGFRβ- 
labelled cells resembling perivascular pericytes (arrow) were not included in the analysis; at higher magnification (H) delicate multipolar processes were apparent on 
some PDGFRβ-labelled cells (lower inset), and their frequent perineuronal positioning was in keeping with NG2 cell types (top inset) and binucleated cells (wavy 
arrow). I. PDGFRβ/MCM2 immunohistochemistry revealed single-labelled populations of MCM2 (arrowheads) and PDGFRβ cells (wavy arrow) as well as co-labelled 
cells (arrow). J. Scatter graph comparing the densities of double-labelled and Olig2 glial populations between FCD and control groups. Bar in A =3 mm and in B, C, F, 
G = ~50 microns, E, H = 25 microns, D (and inset) and I = 10 microns. 
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proliferative fractions could suggest a less significant role of these pro-
genitor cells in this dysplasia type (Garbelli et al., 2015). It is recognised 
that low-grade epilepsy-associated tumours can widely extend along the 
subpial layer and layer I in the adjacent cortex (Blumcke et al., 2019); 
the significantly higher Olig2 and GFAP/MCM2 densities noted in 
FCD3b could arguable reflect tumour progenitor cell infiltration along 
superficial layers rather than co-existing dysplasia. 
5. Conclusions 
Our findings highlight differences in glial regenerative populations 
between dysplasia types of relevance to their divergent underlying ae-
tiologies and potentially to their pathophysiology (Patel et al., 2019), 
warranting their further study. 
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